Shares of Campbell Soup Company (NYSE: CPB) rose over 1% on Friday. The stock has dropped 14% over the past 12 months. The food company is scheduled to report its third quarter 2024 earnings results on Wednesday, June 5, before market open. Here’s a look at what to expect from the report:
Revenue
Analysts are projecting revenue of $2.35 billion for the third quarter of 2024. This compares to net sales of $2.23 billion reported in the same period last year. In the second quarter of 2024, net sales dipped 1% year-over-year to $2.5 billion.
Earnings
The consensus estimate for EPS in Q3 2024 is $0.70, which compares to EPS of $0.68 reported in the year-ago quarter. In Q2 2024, adjusted EPS remained flat at $0.80.
Points to note
As indicated on its last quarterly earnings call, Campbell anticipates a modest sequential improvement in its top line through the remainder of fiscal year 2024. The company expects flat to low single-digit organic net sales growth in the third quarter of 2024, and continued sequential improvement in Q4.
The soup maker has been facing challenges in terms of a category slowdown and a tough economic environment. However, it expects to benefit from the trend of consumers giving priority to value, as they opt to cook meals at home and buy food that allows them to prepare stretchable meals thereby reducing the frequency of their shopping trips. Campbell believes its soup portfolio is suited to meet these needs.
Last quarter, Campbell’s Meals & Beverages segment saw a 2% decrease in sales, with a decline of 3% in US soup. Sales in the Snacks segment remained flat but the company benefited from strength in its power brands.
Campbell completed the acquisition of Sovos Brands and the addition of the latter’s products to its portfolio is expected to drive meaningful growth. Campbell plans to discuss the impact of the acquisition on its FY2024 guidance in its Q3 report.
Another point of note is the company’s recent decision to close its Tualatin, Oregon plant and make production changes at its Jeffersonville, Indiana plant. These actions will result in the reduction of 415 jobs. At the same time, Campbell is investing around $230 million in its newer facilities to drive growth and these projects are expected to create 210 new roles across the organization.
On its last earnings call, Campbell said it expects to see earnings growth and margin progress in the second half of fiscal 2024. The company said it would expect adjusted EPS to be in the lower $0.70 range in Q3.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on